Simplex Trading’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-20
| Closed | -$1K | – | 8487 |
|
|
2018
Q3 | $1K | Buy |
20
+6
| +43% | +$10 | ﹤0.01% | 7287 |
|
|
2018
Q2 | $3K | Buy |
+14
| New | +$34 | ﹤0.01% | 7004 |
|
|
2017
Q4 | – | Sell |
-3
| Closed | -$1K | – | 7315 |
|
|
2017
Q3 | $1K | Sell |
3
-7
| -70% | -$22 | ﹤0.01% | 5754 |
|
|
2017
Q2 | $1K | Buy |
+10
| New | +$44 | ﹤0.01% | 5936 |
|
|
2016
Q4 | – | Sell |
-1
| Closed | -$1K | – | 7156 |
|
|
2016
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 5645 |
|
|
2016
Q2 | $7K | Buy |
+1
| New | +$7 | ﹤0.01% | 4011 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 5407 |
|
|
2015
Q4 | – | Sell |
-9
| Closed | -$30K | – | 6712 |
|
|
2015
Q3 | $30K | Buy |
9
+8
| +800% | +$383 | ﹤0.01% | 2413 |
|
|
2015
Q2 | $1K | Buy |
+1
| New | +$71 | ﹤0.01% | 4984 |
|
|
2015
Q1 | – | Sell |
-19
| Closed | -$22K | – | 6113 |
|
|
2014
Q4 | $22K | Buy |
+19
| New | +$1.81K | ﹤0.01% | 1988 |
|
Simplex Trading's PTX Position: Q2 2019 in Review
Simplex Trading sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2019, closing a stake of 400 shares.
Simplex Trading first reported a position in PTX in Q4 2014 and held it in 12 quarters. The position peaked at $109K in Q4 2014. 0 funds tracked by Wall St. Rank hold PTX as of Q2 2019.
- Simplex Trading reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2019 after selling out during the quarter.
- Simplex Trading sold 400 Pernix Therapeutics Holdings, Inc. shares in Q2 2019.
- Simplex Trading first reported a position in Pernix Therapeutics Holdings, Inc. in Q4 2014 and held it in 12 quarters.
- Simplex Trading's Pernix Therapeutics Holdings, Inc. position peaked at $109K in Q4 2014.
- 0 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2019.
Based on Simplex Trading's 13F filing for Q2 2019, filed 26 Jul 2019.